COMMUNIQUÉS West-GlobeNewswire

3D Signatures Collaborates with MDxHealth to Evaluate Telo-PC™ Test in Prostate Cancer
28/03/2018
TORONTO, March 28, 2018 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V: DXD ) (OTCQB:TDSGF) (FSE:3D0) (the “Company” or " 3DS "), a personalized medicine company with a proprietary software platform (TeloView TM ) based [...]
Glycotope Selects CrownBio as a Preclinical Development Partner to Advance Their Immunotherapeutic Pipeline
28/03/2018
SAN DIEGO, March 28, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing [...]
Avenue Therapeutics Receives Notices of Allowance for Patent Applications Covering Methods of Administration for Intravenous Tramadol
28/03/2018
NEW YORK, March 28, 2018 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI ) (“Avenue”), a company focused on the development and commercialization of intravenous (IV) tramadol, today announced receipt of [...]
Inovalon Announces New Post Acute Care Services Agreement with Tenet Healthcare
28/03/2018
BOWIE, Md., March 28, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV ), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based [...]
Precipio Files Patent for Non-Invasive Cell Capture Device For Gynecological Cancer Detection
28/03/2018
In collaboration with Yale, feminine panty liner designed to remove obstacles to early detection NEW HAVEN, Conn., March 28, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO ), [...]
MacroGenics Announces Pricing of Public Offering of Common Stock
28/03/2018
ROCKVILLE, MD, March 28, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Mersana Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Provides Business Updates
28/03/2018
Enrollment on Track for Phase 1 Trial of XMT-1522 Patients with Advanced Tumors Expressing HER2 Progressing Phase 1 Trial of XMT-1536, First-in-Class Dolaflexin ® Antibody Drug Conjugate Targeting NaPi2b Appointed David [...]
ICC Labs Signs Term Sheet to Acquire Equity Stake in Strategic Partner and Enter the European Market
28/03/2018
Highlights of proposed transaction, include ICC gaining: Access to five important European markets: Germany, United Kingdom, Spain, Italy and France. Use of an established multi-channel distribution network for CBD [...]
Immunovaccine Announces Initiation of Patient Dosing in Investigator-Sponsored Phase 2 Clinical Trial of Its Lead Candidate DPX-Survivac Used in Combination with Pembrolizumab in Patients with DLBCL
28/03/2018
HALIFAX, Nova Scotia, March 28, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that the first patient has been treated in a Phase 2 Study [...]
Nexstim Plc: Decisions of the Board of Directors regarding Board Committees, approval of a financing arrangement and issuance of shares under the restricted share unit plan
28/03/2018
Company announcement, Helsinki, 28 March 2018, at 2 PM Nexstim Plc: Decisions of the Board of Directors regarding Board Committees, approval of a financing arrangement and issuance of shares under the restricted share [...]
Summit Therapeutics Selected for Emerging Science Presentation at the 2018 AAN Annual Meeting
28/03/2018
Summit Therapeutics plc ("Summit", or the "Company") Summit Therapeutics Selected for Emerging Science Presentation at the 2018 American Academy of Neurology Annual Meeting Oxford, UK, and Cambridge, MA, US, 28 March [...]
Edge Therapeutics Provides Update following Interim Analysis of Phase 3 NEWTON 2 Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
28/03/2018
Study Unlikely To Achieve Primary Efficacy Endpoint; DMC Recommends Discontinuation of Study No Unexpected Safety Findings Edge To Reduce Costs and Evaluate Next Steps Edge To Host Conference Call on Wednesday, March 28 [...]
Cesca Therapeutics Inc. Announces Two Abstracts Accepted for Poster Presentation at the International Society for Cellular Therapy (ISCT) 2018 Annual Meeting
28/03/2018
RANCHO CORDOVA, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ: KOOL ) today announced that two late-breaking abstracts involving the use of Cesca’s X-Series™ technologies for cell [...]
Aileron Therapeutics Announces Expansion of Scientific Advisory Board
28/03/2018
CAMBRIDGE, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ: ALRN ), the clinical-stage leader in the field of stapled peptide therapeutics for cancers and other diseases, today announced that [...]
Summit Therapeutics Selected for Emerging Science Presentation at the 2018 American Academy of Neurology Annual Meeting
28/03/2018
OXFORD, United Kingdom and CAMBRIDGE, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT ) (AIM:SUMM) announces that it has been selected for an Emerging Science dual oral and poster [...]
Resverlogix Announces Two New Publications on Apabetalone in Kidney Disease
28/03/2018
CALGARY, Alberta, March 28, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX: RVX ) announced today the publication of two new articles on the effect of apabetalone, a novel small [...]
Aeterna Zentaris Reports Fourth Quarter and Full-Year 2017 Financial and Operating Results
28/03/2018
CHARLESTON, S.C., March 28, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS ) (TSX: AEZS ) today reported financial and operating results for the fourth quarter and year ended December 31, 2017. All Amounts [...]
Hiku Brands and dosist join forces in Canadian market
28/03/2018
TORONTO, March 28, 2018 (GLOBE NEWSWIRE) -- Hiku Brands Company Ltd. (“Hiku”) (CSE:HIKU), Canada’s first vertically-integrated cannabis brand house, is pleased to announce it has entered into a letter of intent to [...]
GENFIT: Presentations at EASL 2018 Annual Congress Highlight Progress in NASH Diagnostics, Combination Therapies and Deep-learning Applications in Medical Imaging
28/03/2018
GENFIT: Presentations at EASL 2018 Annual Congress Highlight Progress in NASH Diagnostics, Combination Therapies and Deep-learning Applications in Medical Imaging Lille (France), Cambridge (Massachusetts, United States [...]

Pages